OOIR: Observatory of International Research

Papers

(The TQCC of Memorias do Instituto Oswaldo Cruz is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease	25
Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-2021	23
The translational challenge in Chagas disease drug development	21
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells	19
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission	16
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy	16
Emerging and reemerging forms of Trypanosoma cruzi transmission	11
Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory	11
Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America	11
Prognosis of chronic Chagas heart disease and other pending clinical challenges	10
Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives	10
Family Herpesviridae and neuroinfections: current status and research in progress	10
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field	10
Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil	9
Perspectives for a new drug candidate for Chagas disease therapy	9
Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis	9
Population movements, borders, and Chagas disease	9
Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi	8
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target	8
Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy	8
Computational approaches towards the discovery and optimisation of cruzain inhibitors	8
Mycolicibacterium fortuitum genomic epidemiology, resistome and virulome	7
Why do we still have not a vaccine against Chagas disease?	7
Urban infestation by Triatoma infestans (Hemiptera: Reduviidae), an overlooked phenomena for Chagas disease in Argentina	7
Chagas disease in the context of the 2030 agenda: global warming and vectors	7

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis	7
Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening	6
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection	6
A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review	6
Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts	6
Is the mitochondrion a promising drug target in trypanosomatids?	6
Flight tone characterisation of the South American malaria vector Anopheles darlingi (Diptera: Culicidae)	6
Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion	5
Epidemiology of paracoccidioidomycosis in Venezuela: a retrospective study from 1954 to 2019	5
An emerging paradigm for the origin and evolution of shelled amoebae, integrating advances from molecular phylogenetics, morphology and paleontology	5
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*	5
Mechanism of action of glycyrrhizin against Plasmodium falciparum	5
Critical analysis of Chagas disease treatment in different countries	5
Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations	5
Differential expression profiles of miRNAs and their putative targets in Schistosoma mansoni during its life cycle	5
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease	5
Antigenicity and adhesiveness of a Plasmodium vivax VIR-E protein from Brazilian isolates	5
Sand fly behavior: much more than weak-flying	4
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon	4
The adaptation of SARS-CoV-2 to humans	4
Detection of non-tuberculosus mycobacteria (NTMs) in lung samples using 16S rRNA	4
Multidisciplinary approach detects speciation within the kissing bug Panstrongylus rufotuberculatus populations (Hemiptera, Heteroptera, Reduviidae)	4
Enterovirus infection and its relationship with neurodegenerative diseases	4
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day	4
Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama	4
Should COVID-19 be branded to viral thrombotic fever?	4
Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’	3
Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil	3
Reemergence of human malaria in Atlantic Forest of Rio Grande do Sul, Brazil	3
Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry	3
Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis	3
Callitrichine gammaherpesvirus 3 and Human alphaherpesvirus 1 in New World Primate negative for yellow fever virus in Rio de Janeiro, Brazil	3
A new Trypanosoma cruzi genotyping method enables high resolution evolutionary analyses	3
Cerebrospinal fluid: a target of some fungi and an overview	3
Giardiasis in urban and rural Amazonas, Brazil is driven by zoonotic and cosmopolitan A and B assemblages	3
Article-processing charges as a barrier for science in low-to-medium income regions	3
Lipid droplets of protozoan parasites: survival and pathogenicity	3
First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil	3
Chagas disease treatment: a 120-year-old challenge to public health	3
First report and genome sequencing of SARS-CoV-2 in a cat (Felis catus) in Colombia	3
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil	3
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon	3
Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain	3
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment	3
Suitability of methods for Plasmodium falciparum cultivation in atmospheric air	3
A short history of innate immunity	3
How is global change affecting Chagas disease landscapes?	3